Open ‐Label, Non‐Mandatory Transitioning From Originator Etanercept to Biosimilar SB4

Arthritis&Rheumatology, EarlyView.

Source: Arthritis and Rheumatology - August 7, 2018 Category: Rheumatology Authors: Lieke Tweehuysen MD , Victor J. B. Huiskes PharmD , Bart J. F van den BemtPharmD, PhD , Johanna E. Vriezekolk PhD , Steven Teerenstra PhD , Frank H. J. van den Hoogen MD, PhD , Cornelia H. van den Ende PhD , Alfons A. den Broeder MD, PhD Source Type: research